// App-Quantinova.ai

3345 : Targeting the YAP1/COX2/SOX2 signaling axis eliminates cancer stem cells in urothelial carcinoma

Researchers

Presenter

  • Akira Oki

Principal Investigators

  • Mohammad Hoque

Medical Centers

  • Johns Hopkins University, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • Cyclooxygenase-2

  • SRY-Box 2

  • Yes Associated Protein 1

Drug/Treatment

  • arsenic

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved